- Investing Ideas
- /
- Swedish Healthcare Undervalued Stocks Based On Cash Flows
Swedish Healthcare Undervalued Stocks Based On Cash Flows
Results
8
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
8 companies
Stille
Market Cap: SEK 2.0b
Manufactures and markets surgical instruments in Sweden and internationally.
STIL
SEK 218.00
7D
7.4%
1Y
20.1%
Carasent
Market Cap: SEK 1.7b
Provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany.
CARA
SEK 22.93
7D
11.5%
1Y
n/a
SyntheticMR
Market Cap: SEK 1.2b
Engages in the development and marketing of imaging and software solutions for magnetic resonance imaging (MRI) in Sweden and internationally.
SYNT
SEK 27.70
7D
0%
1Y
-13.4%
Vimian Group
Market Cap: SEK 19.9b
Engages in the animal health business worldwide.
VIMIAN
SEK 37.90
7D
-4.3%
1Y
17.7%
Humana
Market Cap: SEK 2.3b
Provides individual and family care services for children and adults in Sweden, Finland, Norway, and Denmark.
HUM
SEK 44.65
7D
11.6%
1Y
67.5%
CellaVision
Market Cap: SEK 3.7b
Develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally.
CEVI
SEK 153.40
7D
1.5%
1Y
-29.3%
BrainCool
Market Cap: SEK 417.6m
A medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden.
BRAIN
SEK 1.65
7D
1.7%
1Y
12.1%
Xvivo Perfusion
Market Cap: SEK 8.7b
A medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden, the United States, the Netherlands, Italy, North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania.
XVIVO
SEK 277.60
7D
11.7%
1Y
-16.4%